Virtual Vs Telephone Education in Radiotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Health Network, Toronto
About this trial
The goal of this clinical trial is to compare whether the use of videoconferencing in breast cancer patients undergoing radiotherapy is better for pre-treatment education than telephone calls. The main question it aims to answer is in breast cancer patient receiving radiotherapy, does videoconferencing, compared to telephone calls for pre-treatment education result in decreased procedural fears and concerns? The investigators hypothesize that the use of videoconferencing for pre-treatment radiotherapy education will decrease breast cancer patients' procedural fears and concerns. Researchers will compare the current standard of care in a 30 minute radiation therapist led pre-treatment education call to the intervention of a 45 minute radiation therapist led videoconferencing call to see if the intervention reduces patient procedural fears and concerns, anxiety levels, and has higher patient satisfaction. Participants will be asked to complete questionnaires at three time points: 1. Baseline - at time of study consent. 2. CT-Simulation - after their radiotherapy CT-Simulation appointment. 3. Day 1 Treatment - after their first day of radiotherapy treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years or older
Access to an internet connected device with a microphone and camera
Able to communicate in English with/without a translator
Receiving radical breast cancer radiotherapy
Disqualifiers
Previous radiotherapy treatment
Trial design
Design model
Parallel
Treatments tested in this trial
Videoconferencing Software for Pre-Treatment Education
DeviceVideoconferencing software used for pre-treatment education with face-to-face, patient-to-provider communication using a slide deck with images to help with pre-treatment educational material for radiotherapy
Treatment groups
130 Participants
are divided into 2 treatment groupsGroup A: Standard Care ArmNo intervention 0 interventions
Group B: Videoconferencing ArmActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Cancer Treatment Survey Procedural Fears & Concerns Subscale (CaTS-PC)
11 total questions relating to patients procedural fears and concerns on a Likert-scale (1-5), mean scores are taken from this to generate a procedural fear and concern level out of 5, with lower scores indicating less procedural fears and concerns
Time frame
Measured at three time points (T1-T3). T1: Baseline, T2: exactly after patient CT-Simulation and T3: exactly after patient first day of radiotherapySecondary outcomes
1
Hospital Anxiety and Depression Scale (HADS-A)
7 question survey measured on a 4 point scale (0-3). Total scores are summed and give a indication of patient anxiety levels at the time of completion based. Scores are divided as follows: 0-7 is considered normal, 8-10 is borderline or mild anxiety, and 11-21 is considered severe.
Time frame
Measured at three time points (T1-T3). T1: Baseline, T2: exactly after patient CT-Simulation and T3: exactly after patient first day of radiotherapy2
Satisfaction with Pre-Treatment Radiation Therapy Education Survey
6 likert scale question survey looking at patients overall satisfaction with the specific modality used for pre-treatment education. Looking at the overall appointment, as well as the informational needs of patients. Each question will be looked at individually.
Time frame
Delivered at T2 - exactly after CT-SimulationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov